Prevention
Educational materials that cover preventative measures and harm reduction strategies to prevent the transmission of hepatitis C.
Materials in this section
Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs
A study evaluated the harm reduction counseling that infectious diseases physicians provide to PWID presenting with infections. More
How Did Egypt Eliminate Hepatitis C in Less Than One Year?
An analysis provides details of Egypt’s 100 Million Healthy Lives campaign which, with a modest loan from the World Bank, resulted in the elimination of hepatitis C. More
Global Coverage of Harm Reduction Programs
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review More
Study: French Drug Injection Rooms Cut Emergency Room Visits and Crime
A French study on DCRs in Paris and Strasbourg shows less overdoses, shared needles, abscesses, emergency room visits, public drug use, and crime, compared to cities without DCRs. More
Barriers and Enablers to Testing for Hepatitis C in People who Inject Drugs
Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs – a scoping review of the qualitative evidence More
Harm Reduction Interventions for People who Inject Drugs
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review More
Homeless People Have a Greater Risk for Hepatitis C Reinfection
Recent drug use along with unstable housing increased the risk of acquiring HCV again. More
HIV and Hepatitis C Virus Monitoring Needs to Increase to Achieve Global Elimination Goals
Countries must intensify efforts to track HIV and HCV incidence among people who inject drugs, and to prioritise this group in prevention and elimination work. More
Toward a Vaccine Against Hepatitis C Virus
Recent advances aid the development of vaccines to prevent chronic liver diseases. More
HCV Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: the SToP-C Study
The SToP-C study results were presented at the International Liver Congress, held in London, UK on 22-26 June 2022. More
